Circulation, Vol 77, 353-360, Copyright © 1988 by American Heart Association
M Verstraete, GA Miller, H Bounameaux, B Charbonnier, JP Colle, G Lecorf, GA Marbet, P Mombaerts and CG Olsson
Eight centers participated in a study in which intrapulmonary and
intravenous administration of recombinant tissue-type plasminogen activator
(rt-PA) were compared in 34 patients with acute massive pulmonary embolism.
All patients received intravenous heparin in a bolus of 5,000 IU followed
by 1,000 IU/hr. After 50 mg rt-PA given over 2 hr the severity of embolism,
determined from pulmonary angiograms, declined by 12% in the intrapulmonary
drug group (p less than .005) and 15% in the intravenous drug group (p less
than .005); mean pulmonary arterial pressure fell from 31 +/- 7 to 22 +/- 6
mm Hg (p less than .005) and from 31 +/- 12 to 21 +/- 9 mm Hg (p less than
.005) in the respective groups. After a further 50 mg given over 5 hr (22
patients), the angiographically determined severity of embolism had
decreased by 38% from baseline in the intrapulmonary drug group and by 38%
in the intravenous drug group. The mean pulmonary arterial pressure further
declined to 18 +/- 7 and 12 +/- 5 mm Hg in the respective groups.
Fibrinogen levels dropped to 48% of baseline after 50 mg and to 36% of
baseline after 100 mg rt-PA. Some degree of bleeding at puncture and/or
operation sites was noted in 16 patients, including four who required a
transfusion of two or more units of blood and had been operated on an
average of 7.5 days (range 2 to 13) before thrombolytic treatment was
started.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism
Center for Thrombosis and Vascular Research, Campus Gasthuisberg, Leuven, Belgium.
This article has been cited by other articles:
 |
|
 |
|
  J. A. Kline, M. T. Steuerwald, M. R. Marchick, J. Hernandez-Nino, and G. A. Rose Prospective Evaluation of Right Ventricular Function and Functional Status 6 Months After Acute Submassive Pulmonary Embolism: Frequency of Persistent or Subsequent Elevation in Estimated Pulmonary Artery Pressure Chest, November 1, 2009; 136(5): 1202 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Todd and V. F. Tapson Thrombolytic Therapy for Acute Pulmonary Embolism: A Critical Appraisal Chest, May 1, 2009; 135(5): 1321 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Dellinger Venous Thromboembolic Disease ACCP Crit Care Med Brd Rev, January 1, 2009; 20(0): 197 - 212. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315. [Full Text] [PDF]
|
|
|
|
|
|
C. Kearon, S. R. Kahn, G. Agnelli, S. Goldhaber, G. E. Raskob, and A. J. Comerota Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 454S - 545S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kucher Catheter Embolectomy for Acute Pulmonary Embolism Chest, August 1, 2007; 132(2): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Carlbom and B. L. Davidson Pulmonary Embolism in the Critically Ill Chest, July 1, 2007; 132(1): 313 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jackson, A. Botea, Y. Gubenko, E. Delphin, and H. Bennett Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/pulmonary thrombosis. Anesth. Analg., March 1, 2006; 102(3): 724 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Harris and S Meek When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature Emerg. Med. J., November 1, 2005; 22(11): 766 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tajima, S. Murata, T. Kumazaki, K. Nakazawa, Y. Abe, Y. Komada, P. Niggemann, M. Takayama, K. Tanaka, and T. Takano Hybrid Treatment of Acute Massive Pulmonary Thromboembolism: Mechanical Fragmentation with a Modified Rotating Pigtail Catheter, Local Fibrinolytic Therapy, and Clot Aspiration Followed by Systemic Fibrinolytic Therapy Am. J. Roentgenol., September 1, 2004; 183(3): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Buller, G. Agnelli, R. D. Hull, T. M. Hyers, M. H. Prins, and G. E. Raskob Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 401S - 428S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Robertson Venous thromboembolism: radiological management of high-risk patients Imaging, August 1, 2004; 16(3): 271 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 British Thoracic Society guidelines for the management of suspected acute pulmonary embolism Thorax, June 1, 2003; 58(6): 470 - 483. [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Cable and K. J. Cherry Systemic Thrombolytic Therapy After Recent Abdominal Aortic Aneurysm Repair: An Absolute Contraindication? Mayo Clin. Proc., January 1, 2003; 78(1): 99 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 W. F. Baker Jr Thrombolytic Therapy Clinical and Applied Thrombosis/Hemostasis, October 1, 2002; 8(4): 291 - 314. [PDF]
|
|
|
|
|
|
M. Podbregar, B. Krivec, and G. Voga Impact of Morphologic Characteristics of Central Pulmonary Thromboemboli in Massive Pulmonary Embolism* Chest, September 1, 2002; 122(3): 973 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Cooper and J. A Beckman Massive pulmonary embolism: a remarkable case and review of treatment Vascular Medicine, August 1, 2002; 7(3): 181 - 185. [Abstract] [PDF]
|
|
|
|
|
|
K. E. Wood Major Pulmonary Embolism : Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism Chest, March 1, 2002; 121(3): 877 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Hyers, G. Agnelli, R. D. Hull, T. A. Morris, M. Samama, V. Tapson, and J. G. Weg Antithrombotic Therapy for Venous Thromboembolic Disease Chest, January 1, 2001; 119 (2009): 176S - 193S. [Full Text] [PDF]
|
|
|
|
|
|
G. Sharma, E. D Folland, K. M McIntyre, and A. A Sasahara Long-term benefit of thrombolytic therapy in patients with pulmonary embolism Vascular Medicine, May 1, 2000; 5(2): 91 - 95. [Abstract] [PDF]
|
|
|
|
|
|
S. Z Goldhaber A contemporary approach to thrombolytic therapy for pulmonary embolism Vascular Medicine, May 1, 2000; 5(2): 115 - 123. [Abstract] [PDF]
|
|
|
|
 |
|
 M.D. Thomas, A. Chauhan, and R.S. More Pulmonary embolism--an update on thrombolytic therapy QJM, May 1, 2000; 93(5): 261 - 267. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Arcasoy and J. W. Kreit Thrombolytic Therapy of Pulmonary Embolism: A Comprehensive Review of Current Evidence Chest, June 1, 1999; 115(6): 1695 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M Bravo, R. D Reinhart, and M. F Meyerovitz Percutaneous venous interventions Vascular Medicine, February 1, 1998; 3(1): 61 - 66. [Abstract] [PDF]
|
|
|
|
 |
|
 J. E. Dalen, J. S. Alpert, and J. Hirsh Thrombolytic Therapy for Pulmonary Embolism: Is It Effective? Is It Safe? When Is It Indicated? Arch Intern Med, December 8, 1997; 157(22): 2550 - 2556. [Abstract] [PDF]
|
|
|
|
|
|
L. A. Witty, A. Krichman, and V. F. Tapson Thrombolytic Therapy for Venous Thromboembolism: Utilization by Practicing Pulmonologists Arch Intern Med, July 25, 1994; 154(14): 1601 - 1604. [Abstract] [PDF]
|
|
|
|
 |
|
 A. J. Doorey, E. L. Michelson, and E. J. Topol Thrombolytic Therapy of Acute Myocardial Infarction: Keeping the Unfulfilled Promises JAMA, December 2, 1992; 268(21): 3108 - 3114. [Abstract] [PDF]
|
|
|
|
|
|
S. Z. Goldhaber, M. Morpurgo, the WHO/ISFO Task Force on Pulmonary Embolism, M. L. Brochier, H. Denolin, M. Morpurgo, C. Bosken, H. Bounameaux, J. E. Dalen, P. F. Fedullo, et al. Diagnosis, Treatment, and Prevention of Pulmonary Embolism: Report of the WHO/International Society and Federation of Cardiology Task Force JAMA, October 7, 1992; 268(13): 1727 - 1733. [Abstract] [PDF]
|
|
|
|
|
|
W. Seed Pulmonary embolism: Part 1 Vascular Medicine, March 1, 1991; 2(1): 71 - 83. [PDF]
|
|
|
|
 |
|
 D. W. M. Muller and E. J. Topol Selection of Patients with Acute Myocardial Infarction for Thrombolytic Therapy Ann Intern Med, December 15, 1990; 113(12): 949 - 960. [Abstract] [PDF]
|
|
|
|
 |
|
 E. J. Harris JR and J. M. Porter Thrombolytic Therapy and Modern Vascular Surgery: An Overview Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1989; 2(2): 40 - 63. [PDF]
|
|